Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 5/7/2026China Unveils Sweeping Policy Overhaul to Boost Pediatric Drug Innovat...
  • 5/7/2026Cutia Wins China Approval for CU-30101 Topical Anesthetic Cream
  • 5/7/2026ZTE Partners With China's National Clinical Research Center for Interv...
  • 5/7/2026InnoCare Secures China IND Approval for Novel CDH17-Targeted ADC ICP-B...
  • 5/7/2026Sino Biopharm Wins China Approval for World's First CDK2/4/6 Inhibitor...
  • 5/7/2026Novo Nordisk Signals Delays for Ozempic Generics in China Despite Pate...
  • 5/7/2026GSK Expands China Biotech Push With Up to US$1 Billion siRNA Obesity D...
  • 5/7/2026Amgen Wins China Approval for Evenity (Romosozumab)
  • 5/6/2026NHC Seeks Public Feedback on Updated Rules for Managing Narcotic and P...
  • 5/6/2026NHSA Solicits Comments on National Body Part Coding System to Strength...
  • 5/6/2026China Formalizes Approval Framework for Clinical Use of Biomedical New...
  • 5/6/2026NHC Releases Trial Rules for Approving Clinical Use of Biomedical New ...
  • 5/6/2026NHC Issues Interim Rules Defining Boundaries Between Biomedical New Te...
  • 5/5/2026China Clears 14 Novel INDs Last Week, Spotlighting Obesity, Oncology a...
  • 5/5/2026Gyre Thera Closes $300M Cullgen Deal
  • 5/5/2026U.S. Lawmakers Push to Bar China Clinical Data From FDA Filings, Raisi...
  • 5/5/2026Windward Bio Raises $165M to Advance China-Origin Asthma Drug Into Pha...
  • 5/5/2026Chinese Insulin Wins FDA Approval, Marking Breakthrough Entry Into U.S...
  • 5/5/2026China Tightens Biopharma Supply Chain Controls, Raising Stakes for MNC...
  • 5/5/2026Sinocelltech Advances CD20×CD3 T-Cell Engager Into Phase 3
  • 5/5/2026Bambusa Completes Enrollment in Mid-Stage Trial of Bispecific Antibody...
  • 5/5/2026UCB's $2.2B Candid Deal Highlights China-Origin Innovation Flowing Int...
  • 5/1/2026Recent Official and Executive Moves
  • 5/1/2026Shanghai Pharma Completes Exit from Sino-US JV with $140M Stake Sale t...
  • 5/1/2026EU Approves Henlius–Organon Pertuzumab Biosimilar POHERDY
  • 5/1/2026China Approves Two Innovative Homegrown Therapies Ahead of Holiday Bre...
  • 5/1/2026China Pharma Trade Rises 4.22% in Q1 as Exports Shift Toward High-Valu...
  • 4/30/2026CDE Accepts Bayer Filing for FXIa Inhibitor Asundexian in Secondary St...
  • 4/30/2026Former NMPA Deputy Commissioner Sentenced to 14 Years for Bribery
  • 4/30/2026Livzon Takes Control of Vietnam's Imexpharm in $228M Deal
  • Page:1/62 Total number of articles:1851: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group